Non-Invasive Prenatal testing (Risk free) is a method of determining the risk of the fetus having certain genetic abnormalitiesContact us
Non-Invasive Prenatal testing (Risk free) is a method of determining the risk of the fetus having certain genetic abnormalities such as Down ́s syndrome (T21), Patau ́s syndrome (T13) or Edwards syndrome (T18). We offer a Unique platform with high accuracy and low rejection rate, allowing parents to take important decisions in life. Test available from week-10 of pregnancy.
Blood-sample is collected authorised iLab partner. Sample is sent to iLab for analysis. complete and correct results are normally reported within 10 days.
How it works
Vanadis® NIPT is the only screening assay targeting specific chromosomes without using PCR amplification. Instead, target fragments are directly captured using probes before being converted to circular DNA objects that are replicated to form DNA bundles that are labeled for counting. No replication of DNA is made.
Vanadis® NIPT solution, is-taking all the complexity out of noninvasive prenatal testing, making it accessible to more women – and more cost-effective. This breakthrough cell-free DNA (cfDNA) technology eliminates PCR amplification and gene sequencing, improving number of samples possible to analyze.